Newsletter

Nascent Spirits

Total Labels 1
Approved 1
Expired 0

Batch Brewing Company, Batch Brewing Company L.L.C. — Detroit, MI

Michigan

About Nascent Spirits

Nascent Spirits is a vodka brand originating from Michigan. According to TTB records, the brand produces vodka in the 80-89 proof category. The brand maintains one distinct product group within its vodka line. The company has received one TTB label approval on record, with 2025 noted as the approval year. Nascent Spirits operates within the spirits market as a vodka producer, with its product line registered and approved through the Alcohol and Tobacco Tax and Trade Bureau. The Michigan-based brand's vodka offerings fall within the standard proof range for the category, positioning the products within conventional spirits specifications. As a newer entrant to the market based on recent TTB approval records, Nascent Spirits represents the contemporary vodka production landscape. The brand's single approved label and streamlined product portfolio suggest a focused approach to vodka production and distribution. Consumers seeking information about this Michigan vodka brand can reference the TTB's public COLA registry for verified details regarding label approvals and product classifications.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof
Nascent Spirits

VODKA 80-89 PROOF

Vodka 80-89 Proof Approved 2025-06-30 Batch Brewing Company, Batch Brewing Company L.L.C.

Page 1 of 1

1

Nascent Spirits at a Glance

Nascent Spirits has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2025-06-30 and 2025-06-30. Produced in Michigan.

All information sourced from public TTB records.

Are you the owner or distributor of Nascent Spirits?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Batch Brewing Company, Batch Brewing Company L.l.c.

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.